Company profile for Bexion Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Bexion Pharmaceuticals Inc. is developing innovative cures for cancer. Founded in 2006 when technology was licensed from Cincinnati Children’s Hospital Medical Center, Bexion has developed a first-in-class biologic, BXQ-350, with a novel mechanism of action for targeting and eliminating tumor cells. Mechanism of action studies support potential efficacy across a broad range of tumors, while minimizing “off-target” effect...
Bexion Pharmaceuticals Inc. is developing innovative cures for cancer. Founded in 2006 when technology was licensed from Cincinnati Children’s Hospital Medical Center, Bexion has developed a first-in-class biologic, BXQ-350, with a novel mechanism of action for targeting and eliminating tumor cells. Mechanism of action studies support potential efficacy across a broad range of tumors, while minimizing “off-target” effects. Bexion’s leadership, including the founders, Drs. Ray Takigiku (CEO/President) and Kevin Xu (VP) have significant experience in drug discovery, development and market support of pharmaceuticals.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
632 Russell St. Covington, KY 41011
Telephone
Telephone
1-800-746-3915
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/bexion-pharmaceuticals-inc-announces-acceptance-of-abstracts-at-the-2025-american-society-of-clinical-oncology-asco-annual-meeting-302467512.html

PR NEWSWIRE
28 May 2025

https://www.prnewswire.com/news-releases/bexion-pharmaceuticals-inc-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2025-302438509.html

PR NEWSWIRE
25 Apr 2025

https://www.prnewswire.com/news-releases/bexion-pharmaceuticals-inc-announces-poster-presentation-at-asco-gi-2025-302346390.html

PR NEWSWIRE
08 Jan 2025

https://www.prnewswire.com/news-releases/charles-r-scheper-chairman-of-bexion-pharmaceuticals-board-named-great-living-cincinnatian-302325298.html

PR NEWSWIRE
06 Dec 2024

https://www.prnewswire.com/news-releases/bexion-pharmaceuticals-inc-announces-completion-of-enrollment-in-open-label-portion-of-phase-1b2-asist-study-in-mcrc-302307807.html

PR NEWSWIRE
18 Nov 2024

https://www.prnewswire.com/news-releases/bexion-pharmaceuticals-inc-awarded-grant-from-the-michael-j-fox-foundation-to-advance-bxq-350-302306431.html

PR NEWSWIRE
14 Nov 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty